Sun-Organon buyout shows Indian Pharma's big hunger for overseas M&As — Here's a list of other major deals - Mint
Organon
Apr 27, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Johnson & Johnson has acquired Atraverse Medical, a medical devices business in the United States, for undisclosed terms. Johnson & Johnson acquisitions target Atraverse Medical’s HOTWIRE Transseptal Access System, an FDA-cleared RF guidewire and generator platform for next-generation left-heart access in cardiac ablation. The technology supports electrophysiologists performing left atrium access for atrial fibrillation and other cardiac arrhythmias, with reported use in about 3,000 clinical procedures. The healthcare M&A is an add on acquisition by a strategic buyer, expanding Johnson & Johnson’s MedTech cardiac ablation solutions. Johnson & Johnson expects the strategic acquisition to close in Q2 2026, subject to customary closing conditions.
Source
Read full article on insidermonkey.comvia GN - entered into definitive agreement · April 27, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Organon
Apr 27, 2026
Sun Pharma→Organon
Apr 27, 2026
Sun Pharmaceutical Industries→Organon
Apr 27, 2026
Sun Pharma→Organon
Apr 27, 2026
Sun Pharma→Organon
Apr 27, 2026